tirzepatide and hashimoto's The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care Unveiling Tirzepatide's Therapeutic Spectrum: A
Description
In a statement published on 8 November 2023, the MHRA announced that adults with obesity (a body mass index [BMI] of 30kg/m) or who are overweight (BMI between 2730kg/m) with []
Discuss with your doctor if you are pregnant or plan to become pregnant
Obesity and metabolic disorders are on the rise globally
Results The primary analysis assessing the association between GLP-1 RA use and GRC or aspiration events included 20 retrospective studies with a total of 207,708 patients (23,366 GLP-1 RA users)
Provider guidance and symptom monitoring are essential
